Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (681)
|
Core Tip (766)
|
Full Article (HTML) (2528)
|
Figures (1-1) (505)
|
Full Article (PDF)-1204K (210)
|
Full Article with Cover (PDF)-11949K (253)
|
Full Article (XML)-236K (130)
|
Audio-1342K (11)
|
Peer-Review Report-230K (145)
|
Answering Reviewers-97K (133)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (7878)
|
Similar Articles (78)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (715)
|
Core Tip (764)
|
Full Article (HTML) (1831)
|
Tables (1-1) (583)
|
Full Article (PDF)-358K (171)
|
Full Article with Cover (PDF)-11106K (223)
|
Full Article (XML)-54K (116)
|
Audio-1072K (14)
|
Peer-Review Report-236K (111)
|
Answering Reviewers-62K (107)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6430)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (822)
|
Core Tip (656)
|
Full Article (HTML) (7073)
|
Figures (1-2) (536)
|
Tables (1-5) (538)
|
Full Article (PDF)-1655K (292)
|
Full Article with Cover (PDF)-12399K (252)
|
Full Article (XML)-226K (140)
|
Audio-1259K (12)
|
Peer-Review Report-216K (127)
|
Answering Reviewers-145K (120)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (19)
|
Total Visits (12127)
|
Similar Articles (66)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (787)
|
Core Tip (707)
|
Full Article (HTML) (3851)
|
Figures (1-1) (539)
|
Full Article (PDF)-601K (290)
|
Full Article with Cover (PDF)-11346K (183)
|
Full Article (XML)-89K (130)
|
Audio-384K (11)
|
Peer-Review Report-180K (110)
|
Answering Reviewers-74K (126)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (22)
|
Total Visits (8507)
|
Similar Articles (341)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (759)
|
Core Tip (676)
|
Article Highlights (689)
|
Full Article (HTML) (2606)
|
Figures (1-4) (478)
|
Tables (1-3) (480)
|
Full Article (PDF)-1672K (184)
|
Full Article with Cover (PDF)-12418K (177)
|
Full Article (XML)-173K (114)
|
Audio-467K (8)
|
Peer-Review Report-182K (108)
|
Answering Reviewers-71K (144)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8703)
|
Similar Articles (2096)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (722)
|
Core Tip (735)
|
Article Highlights (847)
|
Full Article (HTML) (2237)
|
Figures (1-3) (556)
|
Tables (1-2) (518)
|
Full Article (PDF)-1874K (190)
|
Full Article with Cover (PDF)-12619K (210)
|
Full Article (XML)-114K (137)
|
Audio-386K (17)
|
Peer-Review Report-233K (128)
|
Answering Reviewers-161K (125)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10205)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (642)
|
Core Tip (611)
|
Article Highlights (680)
|
Full Article (HTML) (1611)
|
Figures (1-4) (461)
|
Full Article (PDF)-5746K (174)
|
Full Article with Cover (PDF)-16492K (171)
|
Full Article (XML)-96K (126)
|
Audio-3997K (11)
|
Peer-Review Report-192K (114)
|
Answering Reviewers-146K (125)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7011)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (714)
|
Core Tip (689)
|
Article Highlights (749)
|
Full Article (HTML) (2801)
|
Figures (1-4) (457)
|
Tables (1-5) (483)
|
Full Article (PDF)-6006K (207)
|
Full Article with Cover (PDF)-16750K (205)
|
Full Article (XML)-200K (119)
|
Audio-376K (9)
|
Peer-Review Report-182K (128)
|
Answering Reviewers-60K (129)
|
Supplementary Material-355K (122)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10929)
|
Similar Articles (1940)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (644)
|
Core Tip (706)
|
Article Highlights (700)
|
Full Article (HTML) (1968)
|
Figures (1-4) (489)
|
Tables (1-4) (479)
|
Full Article (PDF)-5941K (175)
|
Full Article with Cover (PDF)-16687K (184)
|
Full Article (XML)-115K (123)
|
Audio-187K (10)
|
Peer-Review Report-215K (123)
|
Answering Reviewers-37K (137)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (8600)
|
Similar Articles (2594)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (685)
|
Core Tip (699)
|
Full Article (HTML) (1729)
|
Figures (1-1) (536)
|
Full Article (PDF)-5068K (197)
|
Full Article with Cover (PDF)-15813K (172)
|
Full Article (XML)-63K (115)
|
Audio-811K (4)
|
Peer-Review Report-266K (129)
|
Answering Reviewers-225K (128)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7325)
|
Similar Articles (4435)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (682)
|
Core Tip (733)
|
Full Article (HTML) (1698)
|
Full Article (PDF)-325K (146)
|
Full Article with Cover (PDF)-11079K (173)
|
Full Article (XML)-24K (118)
|
Audio-243K (4)
|
Peer-Review Report-215K (98)
|
Answering Reviewers-19K (103)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5273)
|
Similar Articles (402)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
